- $1.05m
- $9.58m
- $4.35m
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 08:29 PM
NASDAQ RESUMED AT 07:40 AM
Brief: ProPhase Labs Signs Non-Binding LOI For Proposed Reverse Merger With Advanced Biological Laboratories
NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM
Brief: Prophase Labs- On Nov 21, Received Confirmation From Avtech Agreeing To Continue Its Forbearance Under Co's Existing Equipment Lease
Brief: Prophase Labs - Aware That Civil Action Pending In The United States District Court For The Eastern District Of New York Has Been Unsealed
Brief: Prophase Labs Reported Results For The Third Quarter Ended September 30, 2025, And Will Hold A Virtual Conference Call Today At 2Pm Et.
Brief: Prophase Labs Urges Shareholders To Vote By November 23 On Proxy Proposals
Brief: ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology
Brief: Prophase Labs enters into sales agreement with Westpark Capital relating to shares
Prophase Labs Inc expected to post a loss of 15 cents a share - Earnings Preview
Brief: Prophase Labs Announces Successful Study Demonstrating Performance Of Be-Smart™ Test In Detecting Esophageal Cancer
Prophase Labs Inc reports results for the quarter ended March 31 - Earnings Summary
Prophase Labs Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: ProPhase Labs Receives Nasdaq Notice For Bid Price Non-Compliance